Namasthe

Find the healthcare and drug approval news of India, China, Japan, Australia and other Asian countries

China Drug Approvals | NMPA Drug Approvals | Pharma | Healthcare | China

April 15, 2022 Tislelizumab was approved in China as second-line therapy for esophageal squamous cell carcinoma BeiGene announced that...

May 31, 2022 GSK announced the approval of Vocabria in combination with Rekambys GSK announced that Japan's Ministry of Health, Labour,...

Jan 31, 2022 PBS listed Calquence for non-Hodgkin lymphoma Australia included Calquence (acalabrutinib) for mantle cell lymphoma, a form...

Feb 23, 2022 Moderna's Spikevax received provisional approval for individuals aged six years and older The Therapeutic Goods...

India started vaccination of adolescents; Bharat Biotech says Covaxin demonstrated robust efficacy and safety in people of age 2-18 years...

China has released the 2021 Drug catalog, which included 2,860 drugs, out of which 1,486 drugs are Western drugs. Reuters reported a...

The U.N. agency World Health Organisation (WHO) had made a statement on the next WHO chief. WHO announced that the member states proposed...

WHO has announced that it has granted emergency use listing for Covaxin developed by Bharat Biotech. This adds another vaccine to the...

Mar 12. 2021 Takeda’s New Drug Application was submitted for MHLW in Japan for Hereditary Angioedema Attacks Takeda announced that it...

SALES FORECAST OF TOP PHARMACEUTICALS IN 2021 Nature Reviews Drug Discovery and Evaluate Pharma published the 2021 sales forecast of...

Novartis entered a strategic collaboration with BeiGene to license tislelizumab; to market in major markets outside China, including...

Bayer has announced that it has submitted an application requesting the approval of vericiguat in China for the treatment of chronic...

Bayer has announced that the Chinese National Medical Products Administration (NMPA) approved Xofigo (radium-223 dichloride) for treating...

Merck has announced that it has received the approval of its anti-PD-1 therapy, Keytruda (pembrolizumab) for radically unresectable,...

The Japanese Ministry of Health, Labor, and Welfare approved AstraZeneca’s Imfinzi (durvalumab) for treating patients with...

INTRODUCTION Japan has a population of 126 million, nearly twice the size of the UK population. Japan is the third-largest economy. The...

Gilead has announced that China’s National Medicinal Products Administration has approved Truvada (emtricitabine 200mg/tenofovir...

Approval of Dayvigo in Japan On July 6th, 2020, Eisai announced that it had launched Dayvigo (lemborexant) in Japan for insomnia. The...

Merck has announced that it has received approval from the Chinese National Medical Products Administration (NMPA) in China for Keytruda...

GSK has announced that Clover Biopharmaceuticals initiated the Phase 1 trial of COVID-19 vaccine SCB-2019. The vaccine was given in...

In Singapore, the Health Sciences Authority has approved three new products in May. Ajovy approved for migraine in adults Tuksya approved...

Gilead has announced top-line Phase 3 trial results of remdesivir in patients with COVID-19. The drug is indicated in moderate COVID-19...